FDA letters track liquid supplement guidance
This article was originally published in The Tan Sheet
Executive SummaryCourtesy letters FDA's Division of Dietary Supplement Programs sent in 2010 appear to follow the agency's 2009 draft guidance on distinguishing liquid supplements from conventional foods (1"The Tan Sheet" Aug. 16, 2010). An April 22 2letter to Tahitian Noni International, posted on FDA's docket Aug. 24, says the Provo, Utah, firm's Tahitian Noni Original Bioactive Beverage products cannot make structure/function claims as long as they are promoted as beverages. A February 3letter to Next Generation Beverages of Hoboken, N.J., and a January 4letter to Nada Beverage Co. of Powder Springs, Ga., similarly preclude the firms' beverage products from making supplement claims. The letters are in response to the companies' notifications of supplement claims
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.